According to the literature, the prevalence of MODY owing to ABCC8 mutations ranges from 0.9 to 3.3% among clinically suspected MODY cohorts [53, 60], possibly equal to 30–50 cases / 1 million individuals. The gene discussed is ABCC8; the disease is MODY.